Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Zosteriform pilar leiomyoma associated with uterine leiomyoma: A case report. | Clin Case Rep | 2023 | 36777791 | PubTator, text mining | PubMed |
| Critical Review on Sustainability in Denim: A Step toward Sustainable Production and Consumption of Denim. | ACS Omega | 2023 | 36777581 | PubTator, text mining | PubMed |
The spectrum of clinical and genetic findings in hereditary leiomyomatosis and renal cell cancer (HLRCC) with relevance to patient outcomes: a retrospective study from a large academic tertiary referral center. | Am J Cancer Res | 2023 | 36777509 | PubTator, text mining | PubMed |
| Biochemical characterization and identification of ferulenol and embelin as potent inhibitors of malate:quinone oxidoreductase from Campylobacter jejuni. | Front Mol Biosci | 2023 | 36776743 | PubTator, text mining | PubMed |
| Fumarate Hydratase Variants and Their Association With Paraganglioma/Pheochromocytoma. | Urology | 2023 | 36773955 | PubTator, text mining | PubMed |
| Mushroom-Derived Compounds as Metabolic Modulators in Cancer. | Molecules | 2023 | 36771106 | PubTator, text mining | PubMed |
| Macrophage Phenotyping in Atherosclerosis by Proteomics. | Int J Mol Sci | 2023 | 36768933 | PubTator, text mining | PubMed |
| Modulating Glycolysis to Improve Cancer Therapy. | Int J Mol Sci | 2023 | 36768924 | PubTator, text mining | PubMed |
| Fumarate Hydratase and S-(2-Succinyl)-Cysteine Immunohistochemistry Shows Evidence of Fumarate Hydratase Deficiency in 2% of Uterine Leiomyosarcomas: A Cohort Study of 348 Tumors. | Int J Gynecol Pathol | 2023 | 36729957 | PubTator, text mining | PubMed |
| Generation and analysis of context-specific genome-scale metabolic models derived from single-cell RNA-Seq data. | Proc Natl Acad Sci U S A | 2023 | 36719923 | PubTator, text mining | PubMed |
| A time differentiated dietary intervention effect on the biomarkers of exposure to pyrethroids and neonicotinoids pesticides. | iScience | 2023 | 36711241 | PubTator, text mining | PubMed |
| Improving Systemic Therapy for Fumarate Hydratase-deficient Renal Cell Carcinoma. | Eur Urol | 2023 | 36682904 | PubTator, text mining | PubMed |
| mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases. | Int J Mol Sci | 2023 | 36674998 | PubTator, text mining | PubMed |
| Druggable Biomarkers Altered in Clear Cell Renal Cell Carcinoma: Strategy for the Development of Mechanism-Based Combination Therapy. | Int J Mol Sci | 2023 | 36674417 | PubTator, text mining | PubMed |
| Pyruvate Dehydrogenase Inhibition Leads to Decreased Glycolysis, Increased Reliance on Gluconeogenesis and Alternative Sources of Acetyl-CoA in Acute Myeloid Leukemia. | Cancers (Basel) | 2023 | 36672433 | PubTator, text mining | PubMed |
| Role of Moonlighting Proteins in Disease: Analyzing the Contribution of Canonical and Moonlighting Functions in Disease Progression. | Cells | 2023 | 36672169 | PubTator, text mining | PubMed |
| Retraction Note: Suppression of fumarate hydratase activity increases the efficacy of cisplatin-mediated chemotherapy in gastric cancer. | Cell Death Dis | 2023 | 36670108 | PubTator, text mining | PubMed |
| Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature. | Curr Oncol | 2023 | 36661719 | PubTator, text mining | PubMed |
| Imaging Methods: Magnetic Resonance Imaging. | Circ Cardiovasc Imaging | 2023 | 36649450 | PubTator, text mining | PubMed |
| Constructing recombinant Saccharomyces cerevisiae strains for malic-to-fumaric acid conversion. | FEMS Microbiol Lett | 2023 | 36646426 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=25